Neale Richmond (Dublin Rathdown, Fine Gael)
Link to this: Individually | In context | Oireachtas source

784. To ask the Minister for Health if patient organisations specific to lung cancer are consulted by him on their approach to lung cancer treatment and supports; if so, the groups; if not, the reason; and if he will make a statement on the matter. [42091/20]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The HSE's National Cancer Control Programme (NCCP) has worked closely with voluntary organisations, including the Irish Cancer Society, Breakthrough Cancer Research and the Marie Keating Foundation, in the design and delivery of lung cancer awareness campaigns.

The NCCP consistently recognises and engages with patient organisations as key partners in relation to survivorship initiatives. To this extent the NCCP has delivered new "Think Lung" resources to improve the early detection of lung cancer for use by primary care and community organisations who work with the population most at risk.  These include educational slides, a partner pack for community organisations and briefing sheets for healthcare professionals. 

The NCCP also supported the Irish Cancer Society Early Detection of Lung Cancer Public Awareness campaign by inputting to intervention design and by providing spokespeople for media interviews.  They also worked with the Marie Keating Foundation to develop and deliver an early detection of lung cancer campaign at end of November 2020.

Neale Richmond (Dublin Rathdown, Fine Gael)
Link to this: Individually | In context | Oireachtas source

785. To ask the Minister for Health if a new approach to lung cancer is required given that Ireland has the second highest rate of lung cancer mortality in Europe; and if he will make a statement on the matter. [42092/20]

Neale Richmond (Dublin Rathdown, Fine Gael)
Link to this: Individually | In context | Oireachtas source

786. To ask the Minister for Health if his Department has carried out research into the reason lung cancer mortality rates are dramatically different for men and women in Ireland; and if he will make a statement on the matter. [42093/20]

Neale Richmond (Dublin Rathdown, Fine Gael)
Link to this: Individually | In context | Oireachtas source

787. To ask the Minister for Health if a female-centred awareness campaign for lung cancer is required given that female mortality rates for lung cancer are dramatically higher than those for men; and if he will make a statement on the matter. [42094/20]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 785 to 787, inclusive, together.

Lung cancer remains the leading cause of cancer mortality among both males and females in Ireland. The National Cancer Registry advises that data from 2015-2017 shows that mortality rates for lung cancer were higher in males (40.3/100,000) compared to females (28.4/100,000).

While cancer incidence and mortality rates are increasing in females and decreasing in males, absolute numbers of lung cancer cases in both sexes are projected to increase significantly by 2035 due to factors including demographic changes in the population, with our increasing and ageing population. Indeed, increasing lung cancer incidence and mortality rates in females have been observed internationally, with recent academic papers highlighting this as a priority area for future research.

Work to increase awareness and early detection of lung cancer is being progressed in line with the National Cancer Strategy. Lung cancer has been chosen as the first cancer on which to focus in a rolling programme of targeted multi-media based public awareness and education campaigns, aimed at the early detection of specific cancers and with particular focus on at-risk populations. The Lung Cancer Awareness Campaign was scheduled for roll-out in April 2020 but was postponed due to the Covid pandemic.

Reducing lung cancer incidence and mortality remains a priority under the National Cancer Strategy 2017-2026. The HSE's National Cancer Control Programme (NCCP) is working to increase awareness and early detection of lung cancer, and to increase survival rates. There have been many improvements in cancer treatment and outcomes over the last number of years, driven by initiatives under successive cancer strategies. It is hoped that the targeted lung cancer awareness campaigns referenced above will result in more cancer's being detected earlier, leading to better outcomes for patients.